Continuous Incisional Lidocaine in Pediatric Patients following Open Heart Surgery
Table 3
Baseline characteristics and univariate analysis.
Global ()
Control group ()
Incisional analgesia group ()
Age (months)
48 (13-83.50)
24 (8-60)
63 (35-98.25)
0.001
Gender: male (, %)
107 (57.8%)
48 (60.8%)
59 (55.7%)
0.548
RACHS1 score
2 (1-4)
2 (2-3)
3 (2-3)
0.033
Extubation in the OR (, %)
131 (70.8%)
42 (53.2%)
89 (84%)
0.001
Intravenous fentanyl (%)
130 (70.3%)
71 (89.9%)
59 (57.3%)
0.001
Days of intravenous fentanyl
2 (1-3)
2 (1-3)
1.5 (1-2)
0.001
Fentanyl dose (mcg/kg/h)
1 (0.5-2)
1 (1-2)
1 (0.5-1.5)
0.001
Intravenous midazolam (%)
51 (27.6%)
32 (40.5%)
19 (17.9%)
0.001
Midazolam dose (mcg/kg/min)
2 (1-2)
2 (1-2)
1.5 (1-2)
0.001
Intravenous propofol (%)
30 (16.2%)
18 (22.8%)
12 (11.3%)
0.044
Propofol dose (mg/kg/h)
1.5 (1-2)
1.5 (1-2)
1.5 (1-2)
0.065
Days of intravenous metamizol
3 (2-5)
3 (2-4)
4 (2-6)
0.001
COMFORT scale
20.1 (18.7-22.3)
19.2 (18-21.5)
21.8 (20-23.5)
0.001
ANALGESIA scale
1.7 (1-2.6)
1.5 (0.97-2.77)
2 (1-2.5)
0.805
Mechanical ventilation (hours)
15.50 (6-24)
12 (6-24)
24 (3-36)
0.198
PICU LOS (days)
4 (3-6)
4 (3-4)
5 (3-8)
0.002
Cualitative variables are expressed in numbers and rates. Cuantitative variables are expressed in medians and interquartile ranges. Significant differences in italic characters. : number of patients.
